First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial
Go back to First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial| (NASDAQ: ACON) | Delayed: 2.38 -0.06 (2.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.44 | 52 Week High | $ | |||
| Open | $2.48 | 52 Week Low | $ | |||
| Day High | $2.60 | P/E | N/A | |||
| Day Low | $2.32 | EPS | $ | |||
| Volume | 79,568 | |||||
| (NASDAQ: ACONW) | Delayed: 0.05 +0.02 (66.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.03 | 52 Week High | $ | |||
| Open | $0.03 | 52 Week Low | $ | |||
| Day High | $0.05 | P/E | N/A | |||
| Day Low | $0.03 | EPS | $ | |||
| Volume | 28,000 | |||||
